The fifth edition of the annual BioSpectrum Asia Pacific clinical research organization (CRO) Survey, which is conduct...
Singapore: Australian drug development company, Biotron, has commenced a landmark phase II human trial of its lead anti...
Singapore: INC Research, a therapeutically focused global clinical research organization (CRO), has implemented Clinical...
Singapore: Kinex Pharmaceuticals and Hanmi Pharmaceutical announced today that the first patient has been enrolled in Ha...
Singapore: Canada-based Quest PharmaTech, a pharmaceutical company developing and commercializing products for the trea...
Singapore: Eurofins Scientific, which provides analytical support to the global pharmaceutical market, has signed an agr...
Singapore: Pharmaceutical Product Development (PPD) has appointed Dr David Johnston as executive vice president of globa...
Singapore: Icon, Ireland-based global provider of outsourced development services to the pharmaceutical, biotechnology a...
Singapore: PRA, a clinical research organization, has opened a second office in China to accommodate its continued expan...
The fifth edition of the annual BioSpectrum Asia Pacific clinical research organization (CRO) Survey, which is conduct...
Singapore: UK-based biopharma company, Xenetic Biosciences, said in a statement that the recruitment process for the tri...
Everything does not seem to be well in the pharmaceutical industry of Asia's third largest economy - India. Although the...
Pharmaceutical and biotechnology companies reap the most benefit from their strategic collaborations, by working with su...
Recruitment and retention of research participants is often the most labor-intensive and difficult component of clinical...
Any regulatory body's primary concern is to provide safe and efficacious medicine at an acceptable healthcare cost to ...
Singapore: Quintiles appointed Ms Jenny Zhang as VP and general manager of Asian laboratories. She will be responsible f...
Singapore: The training of next-generation clinical investigators in China is at the core of a new collaboration between...
The loss of patents on the last generation of blockbuster products has forced multinational pharmaceutical companies t...